Skip to main content
An official website of the United States government

Metformin Hydrochloride in Reducing Metabolic Activity of Cancer Cells in Patients with Head and Neck Squamous Cell Cancer

Trial Status: complete

This pilot early phase I trial studies how well metformin hydrochloride works in reducing metabolic activity of cancer cells in patients with head and neck squamous cell cancer. Metformin hydrochloride may alter markers of metabolism in head and neck cancer cells and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.